Taking omega-3 fatty acid supplements decreases fat buildup in the liver and reduces levels of the liver enzyme gamma-glutamyl transferase in people diagnosed with non-alcoholic fatty liver disease.
Strongly supported
Multiple high-quality studies back this claim.
Not medical advice. For informational purposes only. Always consult a healthcare professional.
Taking omega-3 fatty acid supplements decreases fat buildup in the liver and reduces levels of the liver enzyme gamma-glutamyl transferase in people diagnosed with non-alcoholic fatty liver disease.
See the technical phrasing
Omega-3 fatty acid supplementation reduces intrahepatic triglyceride content and lowers serum gamma-glutamyl transferase (GGT) levels in individuals with non-alcoholic fatty liver disease.
Omega-3 fatty acids enter liver cells and turn on proteins that tell the cell to burn more fat and make less fat. This reduces the amount of fat stored in the liver and decreases stress signals that raise GGT levels in the blood.
What the research says
Supports
1 study
Study: Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
This study provides evidence supporting the claim.
Contradicts
0 studies
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies